Dr Reddy's shares fall on semaglutide supply disruption
after close1 source ↓written by the desknot a recommendation
- Reddy's Laboratories fell
- 3%
- on July 10
- ₹1,230
Shares of Dr Reddy's Laboratories fell 3% to ₹1,230 on July 10, continuing a downward trend. The decline follows a supply disruption of its generic semaglutide, raising concerns over earnings risks and potential delays in commercialization. This situation may jeopardize the company's first-mover advantage in the market.
Not investment advice. For informational purposes only.